Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes

Halina Mikolajek, Miriam Weckener, Z. Faidon Brotzakis, Jiandong Huo, Evmorfia V. Dalietou, Audrey Le Bas, Pietro Sormanni, Peter J. Harrison, Philip N. Ward, Steven Truong, L. Moynié, Daniel K. Clare, Maud Dumoux, Joshua Dormon, Chelsea Norman, Naveed Hussain, Vinod K. Vogirala, Raymond J. Owens, Michele Vendruscolo, James H. NaismithProceedings of the National Academy of Sciences 2022 · DOI

TL;DR

Researchers have uncovered a crucial link between the conformational flexibility of nanobody-SARS-CoV-2 spike protein complexes and binding affinity. By analyzing structural data, they found that nanobodies with less conformational entropy (i.e., more rigid complexes) bind more tightly. This insight was used to engineer a more potent nanobody, offering a promising strategy for developing future antibody-based therapeutics.

What Problem Does This Paper Address?

Developing highly effective antibody-based therapeutics for viruses like SARS-CoV-2 is critical, especially given the emergence of new variants. Nanobodies, single-domain antibodies derived from camelids, are promising candidates due to their small size and ease of engineering. However, nanobodies isolated from naïve libraries often have weak binding affinities, limiting their immediate utility. While affinity maturation techniques can improve binding, understanding the underlying structural principles that govern this improvement is challenging. This paper aims to bridge this gap by investigating the relationship between the structural dynamics of nanobody-spike protein complexes and their binding affinity, seeking to provide a guiding principle for rational nanobody design.

Methods

The study employed a multi-pronged approach combining structural biology, biophysics, and computational analysis:

  • Nanobody Isolation and Maturation: A naïve nanobody library was screened against the SARS-CoV-2 receptor binding domain (RBD) to isolate initial binders. Affinity maturation was then performed through genetic engineering to generate variants with improved binding.
  • Structural Determination: X-ray crystallography and cryo-electron microscopy (cryo-EM) were used to determine the high-resolution structures of various nanobody-RBD and nanobody-spike complexes.
  • Biophysical Characterization: Isothermal titration calorimetry (ITC) and surface plasmon resonance (SPR) were employed to quantitatively measure binding affinities and thermodynamic parameters (enthalpy and entropy) of nanobody-RBD interactions.
  • Computational Analysis: A novel computational approach, Electron Microscopy Inference (EMMI), was used to analyze cryo-EM maps and generate structural ensembles representing the conformational dynamics of the spike-nanobody complexes. This allowed for the quantification of conformational entropy.

Datasets

The study utilized existing structural data from the Protein Data Bank (PDB) and Electron Microscopy Data Bank (EMDB) for various SARS-CoV-2 spike protein and nanobody complexes. No new benchmark datasets were introduced.

Key Insights and Ideas

  • Conformational Entropy as a Key Determinant of Affinity: The most significant finding is the strong correlation between reduced conformational entropy (increased rigidity) in the nanobody-spike complex and higher binding affinity. This suggests that nanobodies that "lock down" the spike protein's flexibility bind more effectively.
  • CDR3 Mutations Indirectly Influence Binding: While sequence mutations were primarily introduced in the CDR3 region of the nanobodies, their impact on binding affinity was not solely due to direct interactions within CDR3. Instead, these mutations subtly altered the nanobody's structure, leading to optimized interactions in other regions, particularly the CDR2-mediated π-cation salt bridge.
  • The π-Cation Salt Bridge is Crucial: The interaction between R52 in the nanobody's CDR2 and E484/F490 on the RBD is a critical determinant of binding. The geometry and ideal arrangement of this interaction were found to correlate with binding affinity.
  • Spike vs. RBD Binding Differences: Nanobodies that bind the isolated RBD often show a decrease in affinity when binding to the full spike trimer. This is attributed to an increased entropic penalty when engaging the more dynamic spike. However, engineered nanobodies can overcome this by gaining enthalpy through interactions with neighboring spike monomers.
  • EM Maps Hold Dynamic Information: The study highlights the value of analyzing cryo-EM maps beyond static atomic coordinates. The EMMI method allows for the extraction of conformational dynamics and entropy, providing actionable insights for rational design.

Key Results

  • A panel of six nanobodies targeting the SARS-CoV-2 RBD was generated, with affinities ranging from micromolar to nanomolar.
  • Structural analysis revealed that nanobodies with higher binding affinity exhibited lower conformational entropy in their complexes with the RBD.
  • A computational analysis using EMMI confirmed a positive correlation between binding affinity (K<sub>D</sub>) and conformational entropy (quantified by RMSF), with a correlation coefficient of 0.85.
  • An engineered nanobody (hybrid) was designed based on these insights, demonstrating improved binding affinity to the spike protein, attributed to a reduced entropic penalty.
  • The engineered hybrid nanobody also showed a different binding mode to the spike trimer, exhibiting flexibility between up and down conformations, which may contribute to its enhanced binding.

Limitations and Future Work

  • Computational Approach Sophistication: While EMMI is powerful, the authors acknowledge that the design approach for the hybrid nanobody, while successful, lacks the sophistication of natural evolutionary selection.
  • Generalizability: The findings are specific to the nanobody family studied and the SARS-CoV-2 spike protein. Further research is needed to determine if these principles apply broadly to other nanobody-antigen interactions.
  • Future Directions: The authors suggest that analyzing the conformational dynamics of EM maps can yield actionable insights for improving nanobody binding affinity. This approach could be applied to the rational maturation of nanobodies against other viral targets and in the development of therapeutics for future pandemics. The potential for nanobodies to be effective in animal models further supports their application in future health crises.

Summary updated

Abstract

Camelid single-domain antibodies, also known as nanobodies, can be readily isolated from naïve libraries for specific targets but often bind too weakly to their targets to be immediately useful. Laboratory-based genetic engineering methods to enhance their affinity, termed maturation, can deliver useful reagents for different areas of biology and potentially medicine. Using the receptor binding domain (RBD) of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein and a naïve library, we generated closely related nanobodies with micromolar to nanomolar binding affinities. By analyzing the structure-activity relationship using X-ray crystallography, cryoelectron microscopy, and biophysical methods, we observed that higher conformational entropy losses in the formation of the spike protein-nanobody complex are associated with tighter binding. To investigate this, we generated structural ensembles of the different complexes from electron microscopy maps and correlated the conformational fluctuations with binding affinity. This insight guided the engineering of a nanobody with improved affinity for the spike protein.
BibTeX
@inproceedings{mikolajek2022correlation,
  author = {Halina Mikolajek and Miriam Weckener and Z. Faidon Brotzakis and Jiandong Huo and Evmorfia V. Dalietou and Audrey Le Bas and Pietro Sormanni and Peter J. Harrison and Philip N. Ward and Steven Truong and L. Moynié and Daniel K. Clare and Maud Dumoux and Joshua Dormon and Chelsea Norman and Naveed Hussain and Vinod K. Vogirala and Raymond J. Owens and Michele Vendruscolo and James H. Naismith},
  title = {{Correlation between the binding affinity and the conformational entropy of nanobody SARS-CoV-2 spike protein complexes}},
  booktitle = {Proceedings of the National Academy of Sciences},
  year = {2022},
  doi = {10.1073/pnas.2205412119},
}
Figure